Tuesday
SESSION 6: MORE ON THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
Moderators:Glenn M. LaMuraglia, MD / Thomas S. Riles, MD  
SESSION 6 SCHEDULE
3:05 PM - 3:10 PM Resolving The Differences Between Various CAS/CEA Guidelines – All Based On The Same Data: How Could They Be So Different
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Abstract      
3:11 PM - 3:16 PM How To Optimize Brain Safety With CAS And CEA: What Is The Significance Of Silent MRI Defects
  Presenter(s):Laura Capoccia, MD, PhD  
  View Abstract      
3:17 PM - 3:22 PM Microemboli And DW MRI Defects After Carotid Interventions: Do They Impair Cognitive Function
  Presenter(s):Wei Zhou, MD  
  View Abstract      
3:23 PM - 3:28 PM Can Asx CS Lead To Cognitive Impairment: Does Carotid Revascularization Produce Cognitive Improvement
  Presenter(s):Brajesh K. Lal, MD  
  View Abstract      
3:29 PM - 3:34 PM Proximal Brain Protection With Flow Reversal vs. Filter Protection For CAS: Which Is Better And How Best To Achieve Flow Reversal
  Presenter(s):Claudio J. Schonholz, MD  
  View Abstract      
3:35 PM - 3:40 PM Flow Reversal Brain Protection Can Be Achieved During CAS With A Modified Mo.Ma Device: How To Do It
  Presenter(s):Juan C. Parodi, MD  
  View Abstract      
EARLY TREATMENT OF SX CS
3:41 PM - 3:46 PM Is CEA Within 48 Hours Of Acute Symptom Onset Safe: The Evidence Is Mixed
  Presenter(s):Martin Bjorck, MD, PhD  
  View Abstract      
3:47 PM - 3:52 PM CEA Early After Symptom Onset Does Not Increase Risk: Not So With CAS
  Presenter(s):Gustav Fraedrich, MD  
  View Abstract      
3:53 PM - 3:58 PM DEBATE: Expedited CEA In Symptomatic CS Patients: How Long Post Symptom Onset Can Patients Safely Undergo CEA
  Presenter(s):Ross Naylor, MD, FRCS  
  View Abstract      
3:59 PM - 4:04 PM DEBATE: Early CAS After Symptom Onset Is Safe In Younger Patients Under Certain Conditions
  Presenter(s):Klaus D. Mathias, MD  
  View Abstract      
4:05 PM - 4:12 PM Panel Discussion
END OF SESSION 6
previous next